140 related articles for article (PubMed ID: 27777210)
1. [RITA combined with temozolomide inhibits the proliferation of human glioblastoma U87 cells].
He XY; Feng XL; Song XP; Zeng HC; Cao ZX; Xiao WW; Zhang B; Wu QH
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1423-1428. PubMed ID: 27777210
[TBL] [Abstract][Full Text] [Related]
2. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
3. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.
Xu P; Zhang G; Hou S; Sha LG
Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
[TBL] [Abstract][Full Text] [Related]
5. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27.
Sang DP; Li RJ; Lan Q
Acta Pharmacol Sin; 2014 Jun; 35(6):832-8. PubMed ID: 24902789
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells.
Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA
Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
[TBL] [Abstract][Full Text] [Related]
8. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
Hirose Y; Berger MS; Pieper RO
Cancer Res; 2001 Mar; 61(5):1957-63. PubMed ID: 11280752
[TBL] [Abstract][Full Text] [Related]
9. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.
Ashizawa T; Akiyama Y; Miyata H; Iizuka A; Komiyama M; Kume A; Omiya M; Sugino T; Asai A; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Int J Oncol; 2014 Jul; 45(1):411-8. PubMed ID: 24820265
[TBL] [Abstract][Full Text] [Related]
10. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
[TBL] [Abstract][Full Text] [Related]
12. Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling.
Hanif F; Perveen K; Malhi SM; Jawed H; Simjee SU
Toxicol In Vitro; 2018 Oct; 52():306-313. PubMed ID: 30003979
[TBL] [Abstract][Full Text] [Related]
13. Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma.
Ono T; Sasajima T; Doi Y; Oka S; Ono M; Kanagawa M; Baden A; Mizoi K; Shimizu H
Nucl Med Biol; 2015 Jul; 42(7):598-607. PubMed ID: 25892210
[TBL] [Abstract][Full Text] [Related]
14. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
[TBL] [Abstract][Full Text] [Related]
15. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G).
Akbarnejad Z; Eskandary H; Dini L; Vergallo C; Nematollahi-Mahani SN; Farsinejad A; Abadi MFS; Ahmadi M
Biomed Pharmacother; 2017 Aug; 92():254-264. PubMed ID: 28551545
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells.
Sur P; Sribnick EA; Patel SJ; Ray SK; Banik NL
Glia; 2005 Apr; 50(2):160-7. PubMed ID: 15685605
[TBL] [Abstract][Full Text] [Related]
18. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells.
Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y
Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046
[TBL] [Abstract][Full Text] [Related]
19. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
Atif F; Patel NR; Yousuf S; Stein DG
PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872
[TBL] [Abstract][Full Text] [Related]
20. Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells.
Ignarro RS; Facchini G; Vieira AS; De Melo DR; Lopes-Cendes I; Castilho RF; Rogerio F
Mol Cell Biochem; 2016 Jul; 418(1-2):167-78. PubMed ID: 27334753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
